FDA Clears New Neurosurgical Port for Deep Brain Access FDA Clears New Neurosurgical Port for Deep Brain Access
The FDA has cleared MindsEye (Minnetronix Medical), the first minimally invasive, expandable and retractable port that allows deep brain access to treat stroke, cancer, and other conditionsFDA Approvals
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Neurology & Neurosurgery News Alert Source Type: news
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Hematology | Neurology | Neurosurgery | Stroke